South San Francisco, CA
Nura Bio revolutionizes the treatment of neurological diseases with novel, life-changing neuroprotective medicines. Nura Bio was conceived in 2018 by The Column Group and its scientific founders.
nurabio.comThese are collections Nura Bio is a part of. Click on the collection name to view similar companies.
Series A
$68,000,000
Series A
$73,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Nura Bio.